Quick Facts

• Visceral belly fat accounts for 77% of obesity’s effect on Alzheimer’s-related brain protein accumulation
• People with high belly fat are 13% more likely to develop neurodegenerative diseases than those with low levels
• Brain changes from visceral fat can occur at age 50, up to 15 years before memory loss symptoms appear

Scientists have identified visceral belly fat as a direct driver of Alzheimer’s disease risk, with new research showing this specific fat type triggers brain protein changes decades before symptoms appear.

The breakthrough study, presented at the Radiological Society of North America, examined 407 participants with an average age of 49 and average BMI of 32. Researchers found that higher levels of visceral fat accounted for 77% of the effect of high BMI on amyloid accumulation in the brain.

“This is the first time we’ve shown the relationship between obesity and Alzheimer’s disease as measured by blood biomarker tests,” said Dr. Cyrus Raji, senior study author at Washington University School of Medicine.

The Visceral Fat Connection

The research revealed a stark difference between fat types. Visceral fat, which surrounds internal organs, directly correlates with increased amyloid and tau proteins – the hallmarks of Alzheimer’s disease. Meanwhile, subcutaneous fat under the skin showed no increase in these harmful proteins.

Male participants with high belly fat developed neurodegenerative diseases at 3.38 per 1,000 person-years compared to 1.82 for low levels. Female participants showed rates of 2.55 for high levels versus 1.39 for low levels.

“Even though there have been other studies linking BMI with brain atrophy or even a higher dementia risk, no prior study has linked a specific type of fat to the actual Alzheimer’s disease protein in cognitively normal people,” said lead researcher Dr. Mahsa Dolatshahi.

How Belly Fat Damages the Brain

Visceral fat releases inflammatory substances and extracellular vesicles that carry harmful signals to the brain. These signals accelerate the buildup of amyloid-β plaques, the sticky proteins that characterize Alzheimer’s disease.

The high visceral fat group also showed lower whole-brain blood flow and increased brain inflammation. This fat type disrupts insulin processing and releases excess hormones that compound the damage.

“Inflammatory secretions of visceral fat may lead to inflammation in the brain, one of the main mechanisms contributing to Alzheimer’s disease,” researchers noted.

Prevention and Treatment Implications

The findings offer hope for prevention. Visceral fat responds better to diet and exercise than subcutaneous fat because it metabolizes more easily.

“The good news is that visceral fat responds well to diet and exercise measures, because visceral fat is more easily metabolized and burned than subcutaneous fat,” the research team reported.

Dr. Raji highlighted the treatment potential: “We have drugs that can treat obesity quite powerfully, which means we could track the effect of weight loss drugs on Alzheimer’s biomarkers in future studies.”

With more than 6 million Americans currently living with Alzheimer’s disease and projections reaching nearly 13 million by 2050, targeting visceral fat emerges as a critical prevention strategy. Obesity now ranks as the top modifiable risk factor for dementia in the United States.

Read more: This Common Body Fat Pattern Is Linked To Higher Alzheimer’s Risk